HomeCompareBFFTF vs DIVO

BFFTF vs DIVO: Dividend Comparison 2026

BFFTF yields 606.06% · DIVO yields 6.49%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BFFTF wins by $280371.14M in total portfolio value
10 years
BFFTF
BFFTF
● Live price
606.06%
Share price
$0.33
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$280371.17M
Annual income
$211,667,981,687.60
Full BFFTF calculator →
DIVO
DIVO
● Live price
6.49%
Share price
$44.85
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$981.68
Full DIVO calculator →

Portfolio growth — BFFTF vs DIVO

📍 BFFTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBFFTFDIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BFFTF + DIVO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BFFTF pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BFFTF
Annual income on $10K today (after 15% tax)
$51,515.15/yr
After 10yr DRIP, annual income (after tax)
$179,917,784,434.46/yr
DIVO
Annual income on $10K today (after 15% tax)
$552.00/yr
After 10yr DRIP, annual income (after tax)
$834.43/yr
At 15% tax rate, BFFTF beats the other by $179,917,783,600.03/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BFFTF + DIVO for your $10,000?

BFFTF: 50%DIVO: 50%
100% DIVO50/50100% BFFTF
Portfolio after 10yr
$140185.60M
Annual income
$105,833,991,334.64/yr
Blended yield
75.50%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BFFTF right now

BFFTF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
-7.4
Piotroski
2/9
DIVO
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BFFTF buys
0
DIVO buys
0
No recent congressional trades found for BFFTF or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBFFTFDIVO
Forward yield606.06%6.49%
Annual dividend / share$2.00$2.91
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$280371.17M$30.7K
Annual income after 10y$211,667,981,687.60$981.68
Total dividends collected$274648.71M$8.2K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: BFFTF vs DIVO ($10,000, DRIP)

YearBFFTF PortfolioBFFTF Income/yrDIVO PortfolioDIVO Income/yrGap
1← crossover$71,306$60,606.06$11,349$649.42+$60.0KBFFTF
2$480,183$403,885.93$12,833$688.83+$467.4KBFFTF
3$3,055,680$2,541,883.57$14,459$727.90+$3.04MBFFTF
4$18,386,820$15,117,242.14$16,238$766.49+$18.37MBFFTF
5$104,687,331$85,013,433.96$18,179$804.47+$104.67MBFFTF
6$564,382,839$452,367,394.46$20,293$841.71+$564.36MBFFTF
7$2,883,114,581$2,279,224,943.60$22,591$878.14+$2883.09MBFFTF
8$13,966,501,456$10,881,568,854.67$25,087$913.65+$13966.48MBFFTF
9$64,208,586,900$49,264,430,341.75$27,791$948.18+$64208.56MBFFTF
10$280,371,169,670$211,667,981,687.60$30,718$981.68+$280371.14MBFFTF

BFFTF vs DIVO: Complete Analysis 2026

BFFTFStock

Biofrontera AG, a biopharmaceutical company, engages in the research, development, and marketing of dermatological products. Its products include Ameluz and BF-RhodoLED lamp for the treatment of mild and moderate actinic keratoses on the face and scalp, field cancerization, and fatal squamous cell carcinoma. The company also develops RhodoLED XL for the treatment of multiple interspersed lesions; Belixos, a modern active cosmetic product for irritated and sensitive skin; and Xepi for the treatment of antibiotic-resistant bacteria. It offers its products primarily in the United States, Europe, and Israel. The company has a collaboration and partnership agreement with Maruho Co., Ltd. Biofrontera AG was founded in 1997 and is headquartered in Leverkusen, Germany.

Full BFFTF Calculator →

DIVOETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this BFFTF vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BFFTF vs SCHDBFFTF vs JEPIBFFTF vs OBFFTF vs KOBFFTF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.